Harriet Joyce Foundation

Our Science,
Medicine &
Technology Advisors

Dr. Arindam Bhattacharjee

Ph.D. , MSc.

Dr. Richard Parad

Associate Professor of Pediatrics

Dr. Alcy Torres

FAAP, MD

Lina Ghaloul Gonzalez

M.D., DCAA, JDH

Nidhi Shah

MD, FACMG

Dr. Edwin Naylor

Founder and Lab Director of Neo Gen Screening

Juan Manuel Acuña A.

MD, MSc, PhD(h), FACOG

Jerry Vockley

MD, PhD, FACMG

Dr. Andres Huerta

Physician

Dr. D. Holmes Morton

Ph.D., M.D

Alyssa Smith

MS, RD, LD, CNSC, Metabolic Dietician

Alyssa Smith

MS, RD, LD, CNSC, Metabolic Dietician

Prof Dorit Nitzan

MD, MPH, RD

Dr. Wahida Karmally

Dr. PH, MS,RDN,CLS,FNLA

Christopher Duggan

M.D., M.P.H

Dr. Richard Parad

Associate Professor of Pediatrics

Dr. Alcy Torres

FAAP, MD

Lina Ghaloul Gonzalez

M.D., DCAA, JDH

Alyssa Smith

MS, RD, LD, CNSC, MD

Dr. Andres Huerta

Physician

Prof Dorit Nitzan

MD, MPH, RD

Sandra Liliana Albornoz Marin

PhD

Nidhi Shah

MD, FACMG

Christopher Duggan

M.D., M.P.H.

Jerry Vockley

MD, PhD, FACMG

Dr. D. Holmes Morton

Ph.D., M.D

Dr. Jia-Sheng Wang

Ph.D., M.D

‘CJ’ Jones (Cheryl Joan Jones)

MD, MPH, RD

Dr. Nesta Bortey-Sam

MD, PhD, FACMG

Kathy Xue

Ph.D., MPH.

Ana María Rule

PhD

Dr. Jia-Sheng Wang

Molecular biomarkers and epidemiology

Dr. Juan Carlos Zevallos

Former minister of health of Ecuador, Dean of School of Medicine at UEES

Dr. Xavier Solorzano

Executive Director of AIE

‘CJ’ Jones (Cheryl Joan Jones)

MD, MPH, RD

Dr. Nesta Bortey-Sam

MD, PhD, FACMG

Prof Dorit Nitzan

MD, MPH, RD

Dr. Wahida Karmally

Dr. PH, MS,RDN,CLS,FNLA

Kathy Xue

Ph.D., MPH.

Ana María Rule

PhD

Sandra Liliana Albornoz Marin

PhD

Christopher Duggan

M.D., M.P.H

Dr. Edwin Naylor

Founder and Lab Director of Neo Gen Screening

Juan Manuel Acuña A.

MD, MSc, PhD(h), FACOG

Dr. Josefina Coloma

BS, PhD

Dr. Edwin Naylor

Founder and Lab Director of Neo Gen Screening

Dr. Donald H. Chace

PhD, MSFS, FAACC

In Memoriam of
Dr. Richard J. Deckelbaum

November 14, 1942-October 2, 2024

It is with profound sorrow that we share the passing of our dear friend and respected mentor of over 30 years, Richard Deckelbaum, on October 2, 2024. Richard was the visionary behind the establishment of both the Division of Pediatric Gastroenterology and the Institute of Human Nutrition at Columbia University. His career was marked by his travels across the globe, championing the health of communities in Africa, Asia, Latin America and the Middle East on issues of infant malnutrition. For all who had the privilege of knowing him, he will be fondly remembered for his brilliance, compassion, thoughtfulness, and unwavering kindness. His radiant smile was truly unforgettable.

Strategic 

Collaborators

Edit Template

Dr. Arindam Bhattacharjee
Senior Investigator and Lab Director, Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School (HMS). A molecular biologist utilizing genomics, developed first Exome and sequencing panels for newborn screening and sick (NICU) infants.

Core Founder, first CEO & CSO of Parabase Genomics and led other Genomics and Informatics projects. Post-doctoral fellowship-Dana Farber Cancer Institute/HMS. Ph.D. Molecular Veterinary Biology, University of Minnesota, USA, MSc. University of Saskatchewan, Canada. 

The focus of Dr. Arindam Bhattacharjee’s has been the development and implementation of innovative genomic tools and translating them for use in population-based newborn screening (NBS) of rare genetic diseases. He is currently a Senior Investigator in the Department of Pediatrics Newborn Genomic Medicine, Brigham and Women’s Hospital.

Dr. Richard Parad
Is an attending neonatologist and Associate Professor of Pediatrics, Department of Pediatric Newborn Medicine, Harvard Medical School Department of Pediatrics, Brigham and Women’s Hospital. 

He directs the Neonatal Genomic Medicine Program at Brigham and Women’s Hospital. Dr. Parad’s research focuses on genomic sequencing for screening and diagnosing disorders in newborns, as well as clinical trials for improving treatment of neonatal lung disorders. He completed his medical degree at the University of California, San Diego, and his residency and fellowship at Boston Children’s Hospital. 

He underwent dual training in Perinatal-Neonatal Medicine and Pediatric Pulmonology at Boston Children’s Hospital. He is the Director of the Program in Newborn Genomics. In addition to caring for newborns in the Newborn Intensive Care Unit (NICU), he is a core member of the Growth and Development Unit (GDU) faculty and the Antenatal Consult team. 

Dr. Alcy R. Torres
 FAAP, received his MD degree at Universidad Central del Ecuador, pediatric residency at Nicklaus Children’s Hospital, Neurology at the Longwood Neurology Program, Harvard Medical School (HMS). 

He then completed the Pediatric Neurology Fellowship at Children’s Hospital Boston, HMS, where he remained on staff for 13 years before becoming the Director of the Pediatric Brain Injury Program at Boston Medical Center and Professor of Pediatrics and Neurology at Boston University Chobanian and Avedisian School of Medicine. 

He is an international leader in pediatric neurology with outstanding clinical, educational, research and publications records. He pioneered a new treatment method for CNS folate deficiency which has changed dramatically the outcome of these patients and is listed as a reference in the NIH library.

Lina Ghaloul Gonzalez
Assistant Professor of Pediatrics Lina Ghaloul Gonzalez, MD, is an assistant professor of pediatrics and a Mellon Scholar within the Division of Genetic and Genomic Medicine, with a secondary appointment in the Department of Human Genetics at the Graduate School of Public Health at the University of Pittsburgh. 

She is native Syrian/Spanish, earned her medical degree from the University of Aleppo School of Medicine in Aleppo, Syria, and a doctorate in Molecular Medicine at the School of Medicine, University of Salamanca, Salamanca, Spain in 2002. She completed her Internal Medicine residency at the State University of New York (SUNY) at Buffalo, Buffalo, New York in 2009 and her residency in Medical Genetics and fellowship in Medical Biochemical Genetics at Pitt/UPMC in 2013.

Ghaloul-Gonzalez became interested in the translational aspect of research including implementation of next generation sequencing and bioinformatics analysis in the diagnosis of genetic disorders and the modern approach to medicine. 

This interest became later more focused on studying the genetic disorders in the Plain community (Amish and Mennonites) in Western PA, the least studied Plain community in the US. Ghaloul-Gonzalez is board-certified in internal medicine, clinical genetics and medical biochemical genetics. 

She is a member of the society for pediatric research (SPR), Society for Inherited Metabolic Disorders (SIMD), American College of Medical Genetics and Genomics (ACMGG), and the American Society of Human Genetics (ASHG).

Nidhi Shah
MD, FACMG, Staff Physician, Genetics and Child Development, Department of Pediatrics, Assistant Director, CGAT, Dartmouth-Hitchcock Medical Center, Assistant Professor of Pediatrics & Pathology and Laboratory Medicine, The Geisel School of Medicine at Dartmouth, Dartmouth Health Children’s. Assistant Director at the Centre for Clinical Genomics and Advanced Technologies at Dartmouth-Hitchcock. Clinical geneticist, Attended Medical school at Smt. N.H.L. Municipal Medical College, Ahmedabad, India, 2014, Residency in pediatrics at Nassau University Medical Center, East Meadow, NY, 2018, and fellowship in Genetics at Boston Children’s Hospital, Harvard Medical School, Boston, MA, 2021.

She currently serves as a Clinical Geneticist at Dartmouth Health Children’s, where her clinical responsibilities include caring for infants, children and adults with genetic disorders in both the inpatient and outpatient settings. She also serves as the Assistant Director of Center for Clinical Genomics and Advanced Technology (CGAT) in the Department of Pathology at Dartmouth Health, working on large-scale NGS deployment with a focus on germline bioinformatics pipeline development to facilitate clinical analysis of whole exome and genome sequencing. Dr. Shah also is part of the core scientific team working on the NIH funded Babyseq2 project, the first-of-its-kind randomized clinical trial designed to examine the medical, social, and economic impacts of integrating genomic sequencing into the clinical care of newborns.   

Her educational efforts focus on teaching medical students, Pediatrics and Pathology residents and genetic counseling students about the fundamentals of medical genetics, embryology, and dysmorphology. She is also interested in emerging technologies such as whole genome sequencing as a method of achieving diagnoses and enabling precision care more efficiently. She works with the International Consortium of Newborn Sequencing as the Lead, Data and Analytics, also co-leading their Data Sharing initiative and established the ICoNS Members-only Network to allow for efficient conversation and collaboration amongst global programs and thought leaders working on newborn sequencing implementation.

Dr. Edwin Naylor
Has been at the forefront of multiplexed newborn screening in the development of tandem mass spectrometry for detection of PKU, MCADD and other inborn errors. Currently the Lab Director of NCGM Genomic Lab in Raleigh NC, an international sequencing laboratory with strong interest in using Next Generation Sequencing and Newborn Screening Filter Papers to allow molecular confirmation diagnosis in newborns with positive biochemical screens. 

NCGM also does whole exome sequencing from Newborn Screening Filter Papers to discover disease-causing gene mutations in high-risk NICU Infants or within regional, sub-populations.

NCGM or a similar lab will be an important resource for confirming diagnosis of positive screens to prevent false positives and to uncover genetic risks, region by region in Ecuador. 

In 2015, Dr. Naylor won the Robert Guthrie Award from the International Society of Neonatal Screening and is a certified diplomat in Clinical Biochemical Genetics (The American Board of Medical Genetics). He has completed his M.P.H from University of Pittsburgh in Human and Population Genetics and Ph.D. from University of Utah in Genetics.

Dr. Juan Manuel Acuña A.
Obstetrics and Gynecology, Clinical Geneticist, Fetal Medicine, Public health; master’s in clinical Epidemiology – Epidemic Intelligence Officer CDC – PhD Honoris Causa, Medical Education Dr. Juan Acuna is a Doctor in Medicine and Surgery from Javeriana University in Colombia, an Obstetrician-Gynecologist with post-graduate Fellowship training in Clinical Genetics (Mount Sinai Medical Center, University of Wisconsin), Fetal Medicine (Fetal Medicine Foundation Diploma, UK), Clinical Epidemiology (INCLEN, UJ), and Field Epidemiology (EIS program, Centers for Disease Control and Prevention, Atlanta). 

He has over 35 years of experience in clinical practice, academic medicine, teaching, and research. He was a full-time Senior Service Fellow for 11 years at the Centers for Disease Control and Prevention in Atlanta, USA. The last three of them as the CDC Maternal and Child Health Program Team Leader. 

He was a full-time University Professor at Universidad Nacional in Colombia for 13 years, faculty at Tulane University in New Orleans for five years, and Funding Associate Professor at Florida International University (FIU) from 2008 until 2019. He was Assistant Vice-president for Research at FIU (2014-2017) and the Founding Chair of the Department of Medical and Population Health Sciences Research. He has had funding from NIH, industry, and academic institutions for his research and programs. He has published and presented more than 65 peer-reviewed papers and more than 20 book chapters.

From 2018-2022 he was the Assistant Dean for Research and the Chair of the Department of Epidemiology and Public Health at Khalifa University College of Medicine and Health Sciences; the Director of the Office of Research and Development at SEHA, Abu Dhabi, UAE.; and the Director for the Research and Data Intelligence Support Center (RDISC) at KU. As of December 9, 2022, he is a full Professor and Associate Dean for Research at the American University of Antigua. He has successfully played a role in the founding and accreditation the FIU HWCOM and UAE KU COMHS.

Dr. Jerry Vockley
Cleveland Family Endowed Pediatric Research, School of Medicine Professor of Human Genetics, Graduate School of Public Health Chief of Genetic and Genomic Medicine, UPMC Children’s Hospital of Pittsburgh Director of the Center for Rare Disease Therapy, UPMC Children’s Hospital of Pittsburgh Dr. Vockley received his undergraduate degree at Carnegie-Mellon University in Pittsburgh, Pennsylvania, and received his MD and PhD degrees in Medicine and Genetics from the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania. 

He completed his pediatric residency at the Denver Children’s Hospital, Denver, Colorado, and his postdoctoral fellowship in Human Genetic and Pediatrics at Yale University School of Medicine in New Haven, Connecticut. Before assuming his current position in Pittsburgh, Dr. Vockley was Chair of Medical Genetics in the Mayo Clinic School of Medicine. Dr. Vockley is internationally recognized as a leader in the field of inborn errors of metabolism. 

His current research focuses on mitochondrial energy metabolism, novel therapies for disorders of fatty acid oxidation and amino acid metabolism, and population genetics of the Plain communities in the United States. He has published over 350 peer reviewed scholarly articles and is the principal or Co-investigator on multiple NIH grants. Dr. Vockley also has an active clinical research program and participates in and consults on multiple gene therapy trials. Dr. Vockley has served on numerous national and international scientific boards including the Advisory Committee (to the Secretary of Health and Human Services) on Heritable Disorders in Newborns and Children where he was chair of the technology committee. 

He is a Fellow in the American Association for the Advancement of Science. He is a Founding Fellow of the American College of Medical Genetics and Genomics, and currently serves on its board of directors. He is co-founder and co-chair of the International Network on Fatty Acid Oxidation Research and Therapy (INFORM). He has served as chair of the Pennsylvania State Newborn Screening Advisory Committee and is a past president of the International Organizing Committee for the International Congress on Inborn Errors of Metabolism and the Society for the Inherited Metabolic Disorders (SIMD). 

He is co-founder and editor of the SIMD North American Metabolic Academy. He provides support for numerous family advocacy groups including MitoAction, the United Mitochondrial Disease Foundation, the Nationaal PKU Association, and the Organic Acidemia Association.

Dr. Andres Huerta 
Physician from the University of Guayaquil, a Specialist in Occupational Health and Safety from the Pontifical Catholic University of Ecuador, He holds a Diploma in Health Services Management from Dr. Rafael Belloso Chacín University – Venezuela. He recently completed his master’s;in clinical nutrition at the University of Guayaquil; Currently, he is a first-year resident in the Postgraduate Program in Traumatology and Orthopedic Surgery at Alcívar Hospital through the International University of Ecuador. 

At the same time, he is pursuing his PhD studies at the University of Los Andes – Venezuela. His research focuses on “The Hand as an Extension of the Self: The Phenomenology of the Injured Body: A Study on Body Perception in Patients with Traumatic Hand Injuries and Loss of Function.

In 2020, Dr. Huerta authored the book, Survival Manual for PKU Parents: How to Survive Your Baby’s First Year with Phenylketonuria, inspired by the metabolic condition that his daughter lives with, Phenylketonuria, which is an Inborn Error of Metabolism.

Dr. D. Holmes Morton
Pediatrician and research physician in the field of pediatric genetics and hereditary metabolic disease. D. HOLMES MORTON M.D. is a pediatrician and co- founder with his wife Caroline of the 1 ST Clinic for Special Children in Strasburg Pennsylvania. In 2012 The Central Pennsylvania Clinic for Special Needs Children; Adults was cofounded as a non-profit organization, a 501c3, as a project during a MacArthur Fellowship. From his Clinic for Special Children, Dr. Morton treats Amish and Mennonite children afflicted with complex medical problems arising from inherited predispositions to disease.

Dr. Morton’s wife Caroline and his brother Paul Morton were involved in establishing similar Clinics in Ohio, Indiana, Wisconsin, and a new Clinic in rural Central Kentucky. These Clinics are medical works-in-progress with the Mission to use knowledge of genetic risks within the populations to improve access to medical care, foster early recognition and improve treatments for inherited disorders. Although the Clinics are local medical practices, the Clinics are recognized internationally for innovative studies in the discovery and treatment of inherited disorders. Publications can be found in Pediatrics, Current Treatment Options in Neurology, Molecular Genetics and Metabolism, Brain, Journal of Pediatrics, Pediatric Transplant, Nature, and Gene Reviews.

In 2020, Dr. Morton received the Rural Health Hero Award. D. Holmes Morton received an M.D. (1983) from Harvard Medical School and completed his residency at Children’s Hospital in Boston. He also conducted biochemical genetics research at Johns Hopkins University and at the Children’s Hospital of Philadelphia.

“Renowned Pediatrician and geneticist D. Holmes Morton left Harvard Medical School to treat children afflicted with genetic illnesses in the Amish country of Pennsylvania. Morton is considered a leading authority on diseases that have plagued groups known to inbreed, as you find in the indigenous and mestizo populations of Ecuador. Using cutting-edge technology, Morton and his team have discovered numerous genetic illnesses and developed novel treatments, says Joseph B. Martin, M.D., former dean of Harvard Medical School. “The care [Morton and his team] provide for these families has no counterpart. He is one of Harvard Medical School’s most remarkable alumni,” says Martin Joseph B. Martin, M.D., former dean of Harvard Medical School.

Alyssa Smith
MS, RD, LD, CNSC, Metabolic Dietician. Aly Smith is a registered and licensed dietitian at University of Pittsburgh Medical Center (UPMC) Children’s Hospital of Pittsburgh, with 2 years of metabolic experience and 10 years pediatric nutrition experience. 

She loves working directly with families and finding food and nutrition solutions to complex metabolic conditions, providing dietary management and support. Alyssa has contributed to several research projects and has been involved in developing nutritional guidelines for managing these conditions. 

Her work focuses on improving the quality of life for affected children through tailored nutritional interventions. She has a Master of Science in Human Nutrition from The Ohio State University (2011) and a Bachelor of Science in Food and Nutrition from Ashland University (2009).  

Prof Dorit Nitzan
Dorit is a pediatrician, nutritionist, epidemiologist, and public health expert who dedicated 17 years serving in the World Health Organization (WHO). She held various high-level positions, including the WHO European Region Emergency Director, the WHO Health Emergency Coordinator, the Emergency Health Operations Manager, the WHO Representative in Ukraine and Serbia (including Kosovo and Montenegro), and the Public Health Manager for the Southeast European Health Network. 

After leading the WHO humanitarian response in Ukraine, she returned to Israel in August 2022 and was appointed a full professor in the Ben Gurion University Faculty of Medicine. Currently, Dorit is the Director of the Master’s Program in Emergency Medicine and the chair of the Ben Gurion University (BGU) Food Systems, One Health and Resilience (BGU-FOR) Research Center.

She is a member of national and international committees focusing on food and nutrition security, health security, community protection and engagement, public health education, humanitarian aid, health emergency prevention, preparedness, response, and recovery.

Dorit has received awards from the WHO, the United Nations, the Israeli Ministry of Foreign Affairs, and the hospitals where she served. Additionally, she volunteers in humanitarian and life-saving organizations and communities.

Dr. Wahida Karmally
Special Research Scientist, Columbia University Associate Editor Journal of Clinical Lipidology. Dr. Wahida Karmally earned her Doctor of Public Health in Health Policy and Management from the Columbia University’s Mailman School of Public Health. She is a Diabetes Educator, and Diplomate of the ACCL (Clinical Lipid Specialist) and is recognized as a Fellow of the National Lipid Association (NLA). She is currently on the faculty for Columbia University’s International Collaboration and Exchange Healthcare Program and Associate Editor for the Journal of Clinical Lipidology. 

Prior to her retirement she was the director of the bionutrition core in the Irving Institute for Clinical and Translational Research at Columbia University for over 30 years. She was on the Faculty in the College of Dental Medicine and Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center. She has published in peer-reviewed journals and text books. Dr. Karmally received the Academy of Nutrition and Dietetics (AND) 2012 Excellence in Practice -Dietetic Research Award. She represented AND at the 2015 Nutrition Mega Event in Brazil and at the American College of Cardiology Roundtable “Managing CV Disease Risk in Diabetes” in 2017. 

She was the 2018 Medallion recipient from the Academy of Nutrition and Dietetics. She served on the Academy of Nutrition and Dietetics’ Panel at the United Nations session on “Women in Science” in February 2020. She has presented at FAO in Italy and nutrition and heart conferences in India, Argentina, UK, Brazil, American Heart Association’s and American Diabetes Association’s Scientific Sessions and is an abstract reviewer for American Diabetes Association and Overseas Dietetic Association. Dr. Karmally served on the Board of Directors of the American Diabetes Association, Asia Pacific Diabetes Action Council, Northeast Lipid Association, Accreditation Council for Clinical Lipidology, New York Heart Association. 

She was a national media spokesperson for the Academy of Nutrition and Dietetics for 11 years and has done over 500 media interviews for print, television and radio. She was Research Chair for the Diabetes Care and Education Practice Group. She served on the Research Committee of the American Association of Diabetes Educators. She is currently a member of the National Lipid Association’s Diversity, Equity and Inclusion Committee.

Christopher Duggan
Is a pediatric gastroenterologist and nutrition physician at Boston Children’s Hospital where he directs the Center for Nutrition. He is Samuel J. Meltzer, MD Professor of Pediatrics in the Field of Gastroenterology and Director of the Division of Nutrition at Harvard Medical School, and Professor in the Departments of Nutrition and Global Health and Population at the Harvard TH Chan School of Public Health. 

He is Medical Director of the Center for Advanced Intestinal Rehabilitation, one of the largest centers in the US for the care of children with intestinal failure/chronic diarrhea syndrome. His clinical activities focus on optimizing outcomes for children with diarrheal diseases and nutritional problems. In a variety of low- and middle-income countries, he and colleagues are evaluating the role of nutritional supplementation in reducing diarrhea and other infectious illnesses in mothers and children. 

He is the founder of the Harvard College course “Nutrition and Global Health” and mentors’ undergraduate, graduate and post-doctoral students at Harvard Medical School and the Harvard TH Chan School of Public Health. Past and present research support has come from the National Institutes of Health, the Gates Foundation, and the World Health Organization. He has consulted with countries including Tanzania and India, to identify important nutritional interventions to improve maternal and child health. 

“Diseases that are easily prevented in the US by clean water, good food and vaccines unfortunately still plague many of the world’s children, and by studying better interventions among children with diarrhea, we can improve medical and nutritional outcomes for all.” In 2019, Dr. Duggan was named Editor-in-Chief of The American Journal of Clinical Nutrition, one of the top-rated peer-reviewed journals in the field of nutrition.

Sandra Liliana Albornoz Marin
PhD, Research Associate, Johns Hopkins Bloomberg School of Public Health, Environmental Health and Engineering. 

Dr. Albornoz is an experienced analytical chemist, with 8 years of experience in analytical chemistry and 1 year in analysis of metals. She has operated the ICP-MS and GC-MS in Dr. Rule’s lab for the past 18 months and is fully familiar with our methods and procedures.

Dr. Jia-Sheng Wang
University of Georgia School of Public Health, Areas of expertise include Environmental health, Food safety, Molecular biomarkers and epidemiology, Molecular toxicology, Natural toxins, mainly mycotoxins. NIEHS Post- doctoral Fellow, 1994-1995, School of Hygiene and Public Health, Johns Hopkins University. 

Specialty: Molecular Epidemiology; Doctor of Philosophy (Ph.D.), 1990-1994, Boston University School of Medicine. Specialty: Pathology and Immunology; Postdoctoral associate research training, 1986-1991, Massachusetts Institute of Technology. Specialty: Toxicology; Member of National Academy of Science; Member of Institute of Medicine.

Doctor of Medicine (M.D.), 1978-1981, Shanghai First Medical College, Shanghai. Specialty: Nutritional Toxicology in Preventive Medicine.

‘CJ’ Jones (Cheryl Joan Jones)
Thirty years living and working across Africa has led CJ Jones to become a passionate food systems disrupter. Driven by the need to create food justice through greater access equity and better use of available resources CJ had built a number of inclusive ‘for profit’ businesses that drive to this vision. Under the umbrella of UTU Food4Good, CJ has built a viable, investor attractive businesses that break the mould in areas as diverse as food waste, innovations around forgotten foods, packaging innovation and cutting-edge food technology.

Born in rural Australia CJ’s thinking has been shaped by environments that are uncompromising to the careless custodian. Misuse of ecosystem services through production waste in a broken supply chain, conspicuous consumption and burgeoning population pressure, especially in fragile eco- systems motivates her disruptive approach to building a new food system. 

Couple this with a professional background as an Investment Banker, administrator, organisational strategist and leader CJ has positioned herself at the edge of change, confident that this view is founded on extensive experience and real insights, prepared to drive investment into this change so that the transformation can be sustainable, equitable and ethical.

Dr. Nesta Bortey-Sam
Assistant Professor, Faculty in Environmental and Occupational Health, University of Pittsburgh School of Public Health. His research focuses on understanding many aspects of environmental toxicology. 

Dr. Bortey-Sam has a BS in Chemistry and MS in Environmental Chemistry from Kwame Nkrumah University of Science & Technology, Ghana, and a PhD in Toxicology from Hokkaido University, Sapporo, Japan, where he also served as a Specially Appointed Assistant Professor. 

He is a certified Chemical Hazard Control Expert. His areas of expertise include chemical/environmental toxicology, environmental health and disease, risk assessment, environmental exposures, public health.

Kathy Xue
Assistant Research Scientist, Department of Environmental Health Science, College of Public Health, University of Georgia. Doctor of Philosophy Interdisciplinary Toxicology Program Department of Environmental Health Sciences University of Georgia 2012-2017 Athens, GA Master of Public Health University of Georgia 2014-2017 Athens, GA Bachelor of Science Cell and Molecular Biology University of Texas – Austin.

Ana María Rule
Assistant Professor, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Education and research Center for Occupational Safety and Health, Director of the Exposure Assessment Laboratories, Department of Environmental Health and Engineering, focuses on the development and evaluation of novel sampling and analysis strategies for assessments of exposure to biological aerosols, e-cigarette aerosols, and particulate matter.

Dr. Juan Carlos Zevallos Lopez

Dean of the Faculty of Health Sciences, Universidad Espíritu Santo (UEES), Minister of Health of Ecuador during the worst health crisis in Ecuador and humanity in the last 100 years. Awarded “Alien of Extraordinary Abilities” by the United States Department of Justice. 

As founding president of the American Chronic Disease Surveillance Network (AMNET), he has established collaboration with 35 universities and non-governmental organizations in 22 countries in the Americas and the Caribbean Associate Professor at Florida International University (FIU) College of Medicine Director of the Health Services Research Endowment Center of the University of Puerto Rico, an entity funded by the NIH and accredited by UNICEF as a Center of Excellence. Doctor graduated from the School of Medicine of the Central University of Ecuador. 

He received his degree in cardiology from the University of Padua, Italy. American Heart Association Fellow to study Preventive Cardiology at the University of Massachusetts Medical School, United States. He completed postdoctoral studies in Field Epidemiology at the Centers for Disease Control and Prevention (CDC) in Atlanta, United States. 

He has extensive experience in clinical and epidemiological aspects of cardiovascular diseases. He is an expert in cardiology, scientific writing and academic curriculum implementation with a solid publication record in English, Italian and Spanish.



Dr. F. Xavier Solórzano

Is the Executive Director of the Foundation Alianza para la Investigación de Enfermedades Emergentes (AIE). He is an international health and development specialist with over thirty years of experience in Africa, Latin America, and the Caribbean working with local and national governments, universities, non-governmental, community, private and international organizations. 

His work includes health and nutrition, water, sanitation and hygiene, technical co-operation, health management, health systems and health financing research, policy development and implementation, research and project management, training, and social and political marketing. 

He received an MD degree from the Universidad Central del Ecuador Medical School, with postgraduate training in health management planning and policy at the Nuffield Centre for International Health and Development of the School of Medicine of the University of Leeds; health economics and planning at The Centre for Health Economics of the University of York; nutrition and health in emergency situations at INCAP, social norms at the University of Pennsylvania; and international health with a concentration in public policy at the Pan American Health Organization.

Dr. Solórzano has worked on the design and implementation of health sector and social development projects with emphasis on organizational changes, financing, decentralization of health services, auditing of service delivery, operational research and institutional building. He has conducted policy analysis, policy development and implementation targeting vulnerable groups.



Dr. Josefina Coloma
PhD. Dr. Coloma has worked in transferring scientific capacity to Latin America since 1993. She has a BS in Biology from the Catholic University in Quito, Ecuador and a PhD in Microbiology and Molecular Genetics from the University of California, Los Angeles. She co-founded the Sustainable Sciences Institute (SSI), served on its Board of Directors since 2000 and is its Executive Director since 2008. 

She is Faculty Researcher (Project Scientist) in the Division of Infectious Diseases and Vaccinology, School of Public Health, at the University of California Berkeley where she has been Co-investigator and Principal Investigator working in several global health programs for almost two decades. Dr Coloma works with international field teams in all research aspects: from study design, compliance to implementation and management. 

Her research has covered dengue and Zika studies involving clinical, pidemiological, community-based and information technology for health projects in Nicaragua and Ecuador. Currently she directs a community-based implementation project in Iquitos Peru to mobilize residents against Aedes aegypti, the main vector for arbovirus transmission, with the use of ICTs. 

She directs several US funded studies on emerging infectious diseases and OneHealth in Northern Ecuador and is principal investigator of the American Asian Centers of Arbovirus Research and Enhanced Surveillance of the NIH Centers for Emerging Disease Surveillance. In addition, she is technical advisor to the Coronavirus and other Respiratory Virus (CORVD) Branch of the USA- Centers of Disease Control. 

Dr Coloma has served as advisor to Ministries of Health in Central and South America, the Organization of American States, WHO and as a member of the Advisory Committee in Health Research for the Pan American Health Organization.

Dr. Donald H. Chace
Is one of the primary developers of the newborn metabolic screening test known as Tandem Mass Spectrometry of Amino Acids and Acylcarnitines. This clinical screening test of dried blood spots collected from newborns was initially developed more than 30 years ago while he was a medical research assistant professor at Duke University Medical Center. 

This method expanded newborn creening for a handful of disorders to more than 35 using a single paper punch from a dried blood spot. He is currently a principal scientist for Capitainer which specializes in quantitative dried blood sampling.